{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:29Z","timestamp":1786119209915,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/mco.0b013e32832d23cd","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T05:04:06Z","timestamp":1249275846000},"page":"526-532","source":"Crossref","is-referenced-by-count":37,"title":["Short bowel syndrome: the role of GLP-2 on improving outcome"],"prefix":"10.1097","volume":"12","author":[{"given":"Katharina","family":"Wallis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian RF","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.gastro.2008.03.043","article-title":"Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up","volume":"135","author":"Pironi","year":"2008","journal-title":"Gastroenterology"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0148607108316198","article-title":"Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats","volume":"32","author":"Koopmann","year":"2008","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1139\/y03-107","article-title":"Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2","volume":"81","author":"Brubaker","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2008.02.014","article-title":"Life in the crypt: a role for glucagon-like peptide-2?","volume":"288","author":"Rowland","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"R5-12-20210204","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.93.15.7911","article-title":"Induction of intestinal epithelial proliferation by glucagon-like peptide 2","volume":"93","author":"Drucker","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/en.2004-1119","article-title":"Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets","volume":"146","author":"Burrin","year":"2005","journal-title":"Endocrinology"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2005.10.004","article-title":"Glucagon-like Peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans","volume":"130","author":"Meier","year":"2006","journal-title":"Gastroenterology"},{"key":"R8-12-20210204","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00365520410004424","article-title":"Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1","volume":"39","author":"Nagell","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/en.2008-1228","article-title":"Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse","volume":"150","author":"Hadjiyanni","year":"2009","journal-title":"Endocrinology"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"G1202","DOI":"10.1152\/ajpgi.90494.2008","article-title":"Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2","volume":"295","author":"Ivory","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365520802538195","article-title":"Glucagon-like peptide-2 increases mesenteric blood flow in humans","volume":"44","author":"Bremholm","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"R12-12-20210204","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/gast.2000.16489","article-title":"Enteroendocrine localization of GLP-2 receptor expression in humans and rodents","volume":"119","author":"Yusta","year":"2000","journal-title":"Gastroenterology"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2005.11.005","article-title":"GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow","volume":"130","author":"Guan","year":"2006","journal-title":"Gastroenterology"},{"key":"R14-12-20210204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.regpep.2004.07.009","article-title":"GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors","volume":"124","author":"Orskov","year":"2005","journal-title":"Regul Pept"},{"key":"R15-12-20210204","doi-asserted-by":"crossref","first-page":"E460","DOI":"10.1152\/ajpendo.00149.2007","article-title":"Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators","volume":"293","author":"Dube","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R16-12-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1210\/en.2007-0561","article-title":"Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I","volume":"149","author":"Dube","year":"2008","journal-title":"Endocrinology"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"R1794","DOI":"10.1152\/ajpregu.90616.2008","article-title":"Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats","volume":"295","author":"Liu","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejphar.2007.08.044","article-title":"Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts","volume":"578","author":"Bulut","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"G211","DOI":"10.1152\/ajpgi.00530.2006","article-title":"Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2","volume":"293","author":"Sigalet","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R20-12-20210204","first-page":"2884","article-title":"In vivo and in vitro degradation of glucagon-like peptide-2 in humans","volume":"85","author":"Hartmann","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-12-20210204","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/endo.141.11.7752","article-title":"Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice","volume":"141","author":"Hartmann","year":"2000","journal-title":"Endocrinology"},{"key":"R22-12-20210204","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/gut.45.4.559","article-title":"Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure","volume":"45","author":"Jeppesen","year":"1999","journal-title":"Gut"},{"key":"R23-12-20210204","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.47.3.370","article-title":"Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon","volume":"47","author":"Jeppesen","year":"2000","journal-title":"Gut"},{"key":"R24-12-20210204","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/gast.2001.22555","article-title":"Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon","volume":"120","author":"Jeppesen","year":"2001","journal-title":"Gastroenterology"},{"key":"R25-12-20210204","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2004.061440","article-title":"Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients","volume":"54","author":"Jeppesen","year":"2005","journal-title":"Gut"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0016-5085(08)60180-8","article-title":"Teduglutide, a novel GLP-2 analog, in the management of short bowel syndrome (SBS) patients dependent on parenteral nutrition: a multicenter, multinational placebo-controlled clinical trial","volume":"134","author":"O'Keefe","year":"2008","journal-title":"Gastroenterology"},{"key":"R30-12-20210204","first-page":"A110","article-title":"Teduglutide, a glucagon-like peptide-2 (GLP-2) analogue, improves fluid balance in short bowel syndrome (SBS) patients depending on parenteral support (PN)","volume":"134","author":"Jeppesen","year":"2008","journal-title":"Gastroenterology"},{"key":"R31-12-20210204","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1359\/jbmr.2003.18.12.2180","article-title":"Role of gastrointestinal hormones in postprandial reduction of bone resorption","volume":"18","author":"Henriksen","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R32-12-20210204","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/003655202317316006","article-title":"Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon","volume":"37","author":"Haderslev","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"R33-12-20210204","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/00365520801965381","article-title":"Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract","volume":"43","author":"Gottschalck","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R34-12-20210204","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1080\/00365520802200028","article-title":"Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome","volume":"43","author":"Gottschalck","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R35-12-20210204","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.2741\/3193","article-title":"Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice","volume":"13","author":"Yazbeck","year":"2008","journal-title":"Front Biosci"},{"key":"R36-12-20210204","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/j.gastro.2006.06.097","article-title":"Effect of teduglutide on patients with moderate-severe Crohn's disease after 8 weeks of therapy: a prospective, double-blind, placebo-controlled trial","volume":"131","author":"Buchman","year":"2006","journal-title":"Gastroenterology"},{"key":"R37-12-20210204","first-page":"110","article-title":"Two dose-equivalent, 21-days, subcutaneous (S.C.), glucagon-like peptide 2 (GLP-2) dosing regimens, 1.0 mg continuously versus 0.33 mg three time daily (tid), in the treatment of short bowel syndrome (SBS) patients","volume":"134","author":"Jeppesen","year":"2008","journal-title":"Gastroenterology"},{"key":"R38-12-20210204","first-page":"427","article-title":"Two dose-equivalent, 56-days, subcutaneous (s.c.), glucagon-like peptide 2 (GLP-2) regimens, 1.6 mg once daily (OD) versus 0.4 mg four times daily (QID), in the treatment of short bowel syndrome (SBS) patients","volume":"134","author":"Jeppesen","year":"2008","journal-title":"Gastroenterology"},{"key":"R39-12-20210204","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1177\/0091270008320605","article-title":"Pharmacokinetics, safety, and tolerability of teduglutide, a glucagon-like peptide-2 (GLP-2) analog, following multiple ascending subcutaneous administrations in healthy subjects","volume":"48","author":"Marier","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"R40-12-20210204","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/me.2004-0196","article-title":"The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1\/2 activation through divergent signaling pathways","volume":"19","author":"Koehler","year":"2005","journal-title":"Mol Endocrinol"},{"key":"R41-12-20210204","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1158\/0008-5472.CAN-08-0029","article-title":"Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells","volume":"68","author":"Koehler","year":"2008","journal-title":"Cancer Res"},{"key":"R42-12-20210204","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jss.2004.04.009","article-title":"Glucagon-like peptide-2: divergent signaling pathways","volume":"121","author":"Rocha","year":"2004","journal-title":"J Surg Res"},{"key":"R43-12-20210204","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/gut.2003.035212","article-title":"Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice","volume":"53","author":"Thulesen","year":"2004","journal-title":"Gut"},{"key":"R44-12-20210204","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jss.2008.05.007","article-title":"Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection","volume":"152","author":"Kaji","year":"2009","journal-title":"J Surg Res"},{"key":"R45-12-20210204","doi-asserted-by":"crossref","first-page":"G643","DOI":"10.1152\/ajpgi.90588.2008","article-title":"Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion","volume":"296","author":"Garrison","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R46-12-20210204","first-page":"687","article-title":"Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor","volume":"61","author":"Boushey","year":"2001","journal-title":"Cancer Res"},{"key":"R47-12-20210204","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.ijrobp.2007.08.051","article-title":"Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat","volume":"69","author":"Torres","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R48-12-20210204","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/micr.20491","article-title":"Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats","volume":"28","author":"Zhang","year":"2008","journal-title":"Microsurgery"}],"container-title":["Current Opinion in Clinical Nutrition & Metabolic Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCO.0b013e32832d23cd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:50Z","timestamp":1786039190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00075197-200909000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mco.0b013e32832d23cd","relation":{},"ISSN":["1363-1950"],"issn-type":[{"value":"1363-1950","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}